THE FEDERATION OF INDIAN GRANITE AND STONE INDUSTRY ELECTED NEW PRESIDENT & GENERAL SECRETARY FOR THE TERM 2024-2026.

 The Federation of Indian Granite and Stone Industry (FIGSI) announced the election of Mr.S.Krishna Prasad as President and Mr.Manoj Kumar Singh as the General Secretary for the term 2024-2026.FIGSI is actively involved in the development of the natural stone & Granite industry. FIGSI also organises trhe STONA exhibition every Two Years. The President, Mr.S.Krishna Prasad,is the Managing Director of M/s Prasad Granites with a legacy of spanning over 50 years. Mr.Manoj Kumar Singh is the Director of M/s Metro Granites & Marbles & ManagingPartner of M/s Metro stones with its operations in more than 40 countries.

The next  STONA 2025 & 16th International Granite & Stone Fair  will be held in Bengaluru at Bangalore International Exhibition Centre (BIEC) from 12th TO 15th February,2025.

Mr.S.Krishna Prasad,President expressed his vision as follows"My primary goal shall be to actively engage for increased visibility and branding of  our Federation while upholding the values that define us.Togetherness and interdependence would be the key words in my journey and as President".He also said that there should be a policy for Waste Disposal . He also said that Karnataka's policy is encouraging for the industry. FIGSI also set up
Two Skill Development Centres in Hosur (Tamilnadu) and in Jaipur (Rajasthan).

RELENTO ANNOUNCES STRATEGIC GLOBAL EXPANSION & LAUNCH OF AI-FIRST LAB & ' RELENTO CARES INITIATIVE'

 RELENTO, a global leader in AI driven business advisory& consulting services,announced a key milestone in their growth story with the launch of AI-First Lab,a global innovation & incubator Hub,at its new state-of-the-art office at IBC Knowledge Park in Bengaluru,Karnataka.The Company also unveiled its Relento Cares inititiative,a community service engagement program focused on uplifting local under privileged & underserved communities across the globe by bridging the digital divide.Through the launch of  Relento cares Initiative,the Company has pledged 1 Million USD towards this global community service initiative.As part of the Relento Cares Initiative, the Company is committed  towards building & equipping a new computer Lab along with additional class rooms at Neraluru Government School with an aim to support Local Bengaluru Community says Mr.Venkatesh Kodangal,Chief Strategy Officer.

" our AI Lab provides a dual purpose platform that supports real world applications and acts as a collaborative hub to nurture innovation.It serves as a beacon for academic institutions across the globe"says Mr.T.P.Vincent,Chief Technology Officer.

Mr.Rajan Gaur,CEO,Relento said, " As part of our global expansion strategy,this new office and AI Innovation Lab in Bengaluru will be a catalyst for our next phase of growth & support our mission to build an AI - first world in collaboration with our customers and partners."

TATA CONSULTANCY SERVICES (TCS) WORLD 10K BENGALURU ON SUNDAY,28,APRIL,2024. CALLED ENDENDIGU BENGALURU-FOREVER BENGALURU.

Procam International, pioneers of the distance running movement  in India  announced the 16th edition of the World Athletics Gold Label Road Race TCS World 10K Bengaluru scheduled on Sunday,28th April,2024from new venue i.e Field Marshal Sam Manekshaw Parade Ground .The World's Premier 10K with a total Prize money of USD 2,10,000,attracts some of the leading Indian& International athletes along with  amateur runners from across the globe.Registration for all races commence on Thursday,15th February at 07.00 AM & will conclude onFriday,29th March,at 11.59 PM as soon as running places are filled ,whichever is earlier.Register now at : https://tcsworld10k.procam.in.To encourage women's participation,a limited number of spots are set aside for women who donot possess a timing certificate.Registration under these criteria will be based on a first come,first served basis.

APOLLO CANCER CENTRES (ACC)- FIRST PRIVATE HOSPITAL IN INDIA TO SUCCESSFULLY COMPLETE CarTCELL THERAPY - NOW INTRODUCES " MADE IN INDIA",CAR T CELL PROGRAM.

Apollo Cancer Centre (ACC),successfully complete CAR-T cell program and to further augment it,the hospital group will now provide access "Made In India" CAR-T cell therapy.CAR-T cell therapies,often known as ""Living Drugs' involve the extraction of a patient's T-Cells (a type of white blood cells whose function is to fight cancer cells,through a process known as Aphersis.These T-Cells are then genetically modified by a safe vehicle (Viral Vector) in a controlled laboratory setting,so that they express modified connectors on their surface called Chimeric Antigen Receptors (CAR's).These CAR's are specifically designed to recognise a protein which is abnormally expressed on certain cancer cells.They are then multiplied to a desired dose,and infused directly into the patient.

CAR-T cell therapies have gained global recogntion for their unparalleled success in transforming the lives of patients with challenging B-cell malignancies. Over 25,000 patients have benefitted worldwide from this therapeutic model.

Dr.Aditya Murali,Senior consultant - Medical & Haemato Oncology,ACC,Bangalore ,sharing insights into the success of the program,he said"having successfully treated patients with imported drugs,we are now poised to treat them with indigenously built therapy".

Dr.Neema Bhat,Consultant- Haematology & Paediatric Oncology,ACC,Bangalore said,"This milestone signifies a new chapter in our fight against cancer,offering renewed hope &possibilities to those battling these conditions".

On this occassion,Mr.Dinesh Madhavan,President,Group Oncology & International,Apollo Hospitals Enterprises Limited,said,"The indigenously built CAR-T treatment,NexCAR19 reflects our commitment to provide transformative & cutting edge cancer care.Apollo Cancer Centres is not just changing the narrative,we are rewriting the possibilities of giving better treatment outcome for cancer patients across India & beyond'.

Dr.Manish Mattoo,CEO,Karnataka region,Apollo Hospitals, said," we are proud to be the first in India to achieve the milestone of groundbreaking success in CAR-T cell Therapy & this achievement reflects our dedication to pushing healthcare boundaries & delivering impactful solutions to the community".

In a layman's language,CAR-T cell therapy  reprogramme the body's immunity by harnessing the resources of the  body of the patient to fight by using the body's immunity.This treatment is mainly used for blood cancer Now.

ASTER CMI HOSPITAL UNVEILS A PATH BREAKING INNOVATION IN AI - ENDOWMENT TO THE FUTURE OF HEALTH CARE.

 Aster CMI Hospital,charges ahead as a Health care patron with its groundbreaking innovative technology, which supports the health experts on various aspects of treatment such as analyzing vast amounts of data that could lead to accurate diagnosis of diseases earlier,developing new treatment options, and immediate monitoring of vitals for various specialties. 

AI Carpal Tunnel Syndrome (CTS) is one such technology that is developed by the neurology department  which is poised to revolutionize nerve ultra sound diagnostics. This technology redfines,diagnoses and screens efficiently.It can identify the median nerve in ultra sound videos and detect CTS with the highest accuracy (95%)making a significant leap in health care innovation.The AI tool signifies a transformative stride towards precision and efficiency in CTS diagnostics,marking a new era in healthcare.

Mr.Ramesh Kumar.S.CEO,Aster Hospitals said," The hospital has been at the forefront,seamlessly weaving human expertise with AI to usher in a new era in healthcare excellence and actively engaging in collaborative efforts with providers,researchers and innovators to unlock the full potential of AI for the greater good of humanity".

Commenting on the occasion,Dr.Lokesh Bathala,Lead Consultant Neurology, said," This Lab is an exemplification to the unlimited potential of AI in Health Care.These AI tools can prevent long term complications & improve the quality of life.It can also minimize the need for repetetive examinations and invasive procedures,reducing patient's discomfort and anxiety.While the AI tools significantly reduce the inference time,it is important to note that the final diagnosis will always be carried out by the physician". This transformative technology -enabled tool marks new dawn in health care says       Dr.Nitish Shetty, DM Healthcare.

Dr.Phanindra,from  Indian Institute of Science who has set up the Lab at the Hospital said,: It is just the beginning & AI redefines diagnosis & screening"